HMG-CoA reductase inhibitors and bile lithogenicity: cholesterol supersaturation or nucleation defect?
作者信息
Ahmed H A, Jazrawi R P, Northfield T C
机构信息
St George's Hospital Medical School, London, UK.
出版信息
Eur J Gastroenterol Hepatol. 1996 Mar;8(3):195-6. doi: 10.1097/00042737-199603000-00001.
Abstract
摘要
相似文献
1
HMG-CoA reductase inhibitors and bile lithogenicity: cholesterol supersaturation or nucleation defect?
Eur J Gastroenterol Hepatol. 1996 Mar;8(3):195-6. doi: 10.1097/00042737-199603000-00001.
2
Does the HMG-CoA reductase inhibitor pravastatin influence nucleation of cholesterol crystals in supersaturated model bile?
Eur J Gastroenterol Hepatol. 1996 Mar;8(3):197-200. doi: 10.1097/00042737-199603000-00002.
3
Effect of CS-514, a competitive inhibitor of hydroxymethylglutaryl coenzyme A reductase, on cholesterol gallstone formation in hamsters.羟甲基戊二酰辅酶A还原酶竞争性抑制剂CS-514对仓鼠胆固醇胆结石形成的影响。
Biochim Biophys Acta. 1989 Sep 11;1005(1):65-71. doi: 10.1016/0005-2760(89)90032-5.
4
Inhibitory effects of pravastatin, a competitive inhibitor of hydroxymethylglutaryl coenzyme A reductase, on cholesterol gallstone formation in prairie dogs.羟甲基戊二酰辅酶A还原酶竞争性抑制剂普伐他汀对草原犬鼠胆固醇胆结石形成的抑制作用。
Digestion. 1992;51(3):179-84. doi: 10.1159/000200894.
5
Effect of withdrawal of pravastatin on biliary lipid composition in humans.
Atherosclerosis. 1996 Jun;123(1-2):133-7. doi: 10.1016/0021-9150(96)05795-4.
6
Simvastatin, a competitive inhibitor of HMG-CoA reductase, lowers cholesterol saturation index of gallbladder bile.辛伐他汀是一种HMG-CoA还原酶的竞争性抑制剂，可降低胆囊胆汁的胆固醇饱和指数。
Hepatology. 1988 Sep-Oct;8(5):1147-50. doi: 10.1002/hep.1840080531.
7
Role of fibrates and HMG-CoA reductase inhibitors in gallstone formation: epidemiological study in an unselected population.贝特类药物和HMG-CoA还原酶抑制剂在胆结石形成中的作用：一项非选择性人群的流行病学研究
Dig Dis Sci. 2001 Mar;46(3):540-4. doi: 10.1023/a:1005643014395.
8
Nucleation time and fatty acid composition of lecithin in human gallbladder bile.人胆囊胆汁中卵磷脂的成核时间及脂肪酸组成
Scand J Gastroenterol. 1993 Feb;28(2):131-6. doi: 10.3109/00365529309096059.
9
Effects of long-term treatment with low-dose pravastatin on biliary lipid and bile acid composition in patients with nonfamilial hyperlipoproteinemia.
Metabolism. 1995 Nov;44(11):1410-2. doi: 10.1016/0026-0495(95)90138-8.
10
Reduced cholesterol absorption in hamsters by crilvastatin, a new 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor.新型3-羟基-3-甲基戊二酰辅酶A还原酶抑制剂西立伐他汀降低仓鼠胆固醇吸收的作用
Eur J Pharmacol. 1997 Feb 5;320(1):65-71. doi: 10.1016/s0014-2999(96)00882-5.
引用本文的文献
1
Role of fibrates and HMG-CoA reductase inhibitors in gallstone formation: epidemiological study in an unselected population.贝特类药物和HMG-CoA还原酶抑制剂在胆结石形成中的作用：一项非选择性人群的流行病学研究
Dig Dis Sci. 2001 Mar;46(3):540-4. doi: 10.1023/a:1005643014395.
Zotero 插件